Lupin Limited LUPIN.NS Stock
Lupin Limited Price Chart
Lupin Limited LUPIN.NS Financial and Trading Overview
| Lupin Limited stock price | 1630.15 INR |
| Previous Close | 834.75 INR |
| Open | 838.75 INR |
| Bid | 838.8 INR x 0 |
| Ask | 838.9 INR x 0 |
| Day's Range | 836.8 - 839.55 INR |
| 52 Week Range | 592.9 - 839.55 INR |
| Volume | 94.81K INR |
| Avg. Volume | 1.07M INR |
| Market Cap | 381.82B INR |
| Beta (5Y Monthly) | 0.578767 |
| PE Ratio (TTM) | 89.06582 |
| EPS (TTM) | 39.26 INR |
| Forward Dividend & Yield | 4 (0.48%) |
| Ex-Dividend Date | July 14, 2022 |
| 1y Target Est | 743.18 INR |
LUPIN.NS Valuation Measures
| Enterprise Value | 401.11B INR |
| Trailing P/E | 89.06582 |
| Forward P/E | 22.160591 |
| PEG Ratio (5 yr expected) | 2.78 |
| Price/Sales (ttm) | 2.2943654 |
| Price/Book (mrq) | 3.0602567 |
| Enterprise Value/Revenue | 2.41 |
| Enterprise Value/EBITDA | 23.313 |
Trading Information
Lupin Limited Stock Price History
| Beta (5Y Monthly) | 0.578767 |
| 52-Week Change | 39.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 839.55 INR |
| 52 Week Low | 592.9 INR |
| 50-Day Moving Average | 749.45 INR |
| 200-Day Moving Average | 716.96 INR |
LUPIN.NS Share Statistics
| Avg. Volume (3 month) | 1.07M INR |
| Avg. Daily Volume (10-Days) | 728.01K INR |
| Shares Outstanding | 455.06M |
| Float | 240.39M |
| Short Ratio | N/A |
| % Held by Insiders | 47.27% |
| % Held by Institutions | 37.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 0.47% |
| 5 Year Average Dividend Yield | 65.00% |
| Payout Ratio | 0.42509997 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 2.58% |
| Operating Margin (ttm) | 5.04% |
| Gross Margin | 59.26% |
| EBITDA Margin | 10.33% |
Management Effectiveness
| Return on Assets (ttm) | 2.34% |
| Return on Equity (ttm) | 3.61% |
Income Statement
| Revenue (ttm) | 166.42B INR |
| Revenue Per Share (ttm) | 366.05 INR |
| Quarterly Revenue Growth (yoy) | 14.09% |
| Gross Profit (ttm) | N/A |
| EBITDA | 17.21B INR |
| Net Income Avi to Common (ttm) | 4.3B INR |
| Diluted EPS (ttm) | 9.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.33B INR |
| Total Cash Per Share (mrq) | 38.12 INR |
| Total Debt (mrq) | 45.42B INR |
| Total Debt/Equity (mrq) | 36.21 INR |
| Current Ratio (mrq) | 1.344 |
| Book Value Per Share (mrq) | 274.16 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 18.97B INR |
| Levered Free Cash Flow (ttm) | 581.48M INR |
Profile of Lupin Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | Kalpataru Inspire |
| ZIP | 400055 |
| Phone | 91 22 6640 2323 |
| Website | https://www.lupin.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited network consists of 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Q&A For Lupin Limited Stock
What is a current LUPIN.NS stock price?
Lupin Limited LUPIN.NS stock price today per share is 1630.15 INR.
How to purchase Lupin Limited stock?
You can buy LUPIN.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lupin Limited?
The stock symbol or ticker of Lupin Limited is LUPIN.NS.
Which industry does the Lupin Limited company belong to?
The Lupin Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Lupin Limited have in circulation?
The max supply of Lupin Limited shares is 455.98M.
What is Lupin Limited Price to Earnings Ratio (PE Ratio)?
Lupin Limited PE Ratio is 41.52190800 now.
What was Lupin Limited earnings per share over the trailing 12 months (TTM)?
Lupin Limited EPS is 39.26 INR over the trailing 12 months.
Which sector does the Lupin Limited company belong to?
The Lupin Limited sector is Healthcare.